Article
Targeting the epithelium in pulmonary fibrosis.
European respiratory review : an official journal of the European Respiratory Society - 1 Jan 2026
Lizé Muriel, Mayr Christoph H, Bleck Marina, Wollin Lutz, Wohnhaas Christian T, Shalashova Irina, Olbrich Heiko, Heilker Ralf, Engler Anna, Bammert Marie-Therese, Schlüter Holger, Geillinger-Kästle Kerstin, Soetopo Devona, Klee Stephan, Wolf Felix, Gokey Jason J, Stahl Heiko, Klimowicz Alexander C, McCall A Scott, Kropski Jonathan A, Blackwell Timothy S, Thomas Matthew J
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive scarring primarily of the distal regions of the lung in a distinctive histological pattern. Consequently, drug discovery has focused on the activity of scar-forming fibroblasts, with some success shown by the pharmaceutical agents nintedanib and pirfenidone, and more recently nerandomilast. Yet an unmet medical need remains, pointing toward...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
